Viola Cereda

Viola Cereda is passionate and deeply immersed in the study of beer and data. She is an active member of the Italian Society of Sensory Sciences. As Sensory Team Coordinator at VINHOOD, she leads the interpretation of sensory data to uncover actionable insights. She specializes in supporting beer industry partners with data-driven strategies tailored to consumer taste preferences

Quentin Horgan, MSc, BSc

Quentin Horgan, MSc, BSc, is Associate Director of the drugs database at GlobalData. With over 7 years of experience working amongst pharmaceutical Intelligence presiding over multiple presentations and insightful reports during his time in GlobalData and supporting clients on significant campaigns. His primary responsibilities include reviewing and updating drug information presented on GlobalData’s drug module, as well as the maintenance of data quality through quality control and timely client support.

Quentin is also involved in the production of analytical reports and insights, as well as testing database releases. He has a firm understanding of all aspects of the pharmaceutical market, drugs development, and marketing. Quentin holds a MSc in Drugs Discovery and Pharma Management from University College London and a BSc in Biochemistry from the University of Sussex.

Marc Ebben

Marc Ebben, started as Strategic Customer Manager Food & Beverage at Adven in January 2024, focussing on connecting with major manufacturers in the Food & Beverage industry. Before joining Adven he has been active in the renewable energy business before for 4 years at Unisun Energy as Business Development Manager of large scale solar and battery projects in Europe and for almost 20 years in the packaging industry in various sales, business development, plant management and director roles. He started his journey in the packaging industry with Kappa (Smurfit Westrock nowadays) and followed by Weidenhammer Packaging, later Sonoco, before moving to Stora Enso and Corex (part of VPK).

Christine Goffe

Passionate about sciences and technologies, Christine studied bioengineering at the Catholic University of Louvain (UCL) in Belgium. After having held several roles in the pharma industry, mainly in Clinical Data Management and Data Surveillance, she took over the role Team Lead Centralized Monitoring at UCB. The team is responsible for Central Monitoring activities, using Key Risk Indicators (KRIs), Quality Tolerance Limits (QTLs) and Central Statistical Monitoring tools to detect data anomalies and trends at study, site, and study participant level.

Manan Trivedi MSc, PhD, EMBA

Manan Trivedi, PhD, is a clinical and regulatory project management leader with 15+ years of experience in the pharmaceutical industry, specializing in global clinical trial submissions, regulatory compliance, and process optimization.

As ASSOCIATE DIRECTOR & EU CTR PROJECT LEAD at UCB Biopharma, he spearheads the end-to-end implementation of the EU Clinical Trial Regulation (EU CTR), ensuring streamlined regulatory pathways, cross-functional coordination, and operational efficiencies. His leadership in transitioning trials from CTD to CTR has positioned UCB as an industry front-runner in regulatory compliance.

Cindy Weiss

Cindy Weiss is a speaker on patient-centred packaging systems for remote sample collection and multiomics research.
With a background in industrial design and health innovation, her work focuses on human-centred design, patient engagement, and remote clinical trials.
Through her talks, she shares insights on precision diagnostics, cross-sector collaboration, and the role of design in advancing personalised healthcare.

Valerie Schwartz

Valerie Schwartz, Accorto’s Regulatory Affairs Manager, brings strong experience in regulatory operations and scientific research within the nicotine and tobacco harm reduction space. At Juul Labs, she began as an analytical chemistry scientist supporting new product research and development and later transitioned into the Regulatory Operations team, where she led key non-clinical regulatory science projects in support of FDA engagement and product submissions.

At Accorto Regulatory Solutions, Valerie plays a central role in the preparation of FDA submissions for a wide range of nicotine products, including next-generation products. She works cross functionally to manage the development and review of scientific documentation across multiple disciplines, including chemistry, stability, toxicology, and safety assessments. She also monitors and interprets FDA guidance and regulatory trends, integrating strategic updates into scientific testing and submission strategies to ensure each application meets current regulatory expectations.

Amelia Lowe

Amelia Lowe, as the Vice President of Operations at SquareTrade Europe, leads all claims and operational functions across the region. With oversight of Supply Chain, Customer Service, Customer Experience, Solutions & Sustainability, Amelia plays a pivotal role in driving operational excellence and enabling profitable growth. Boasting a ten-year tenure at SquareTrade, Amelia advanced through senior management roles in operations and supply chain before assuming her current position. 

Prior to SquareTrade, Amelia ran her own consulting business, specialising in innovation and strategic guidance for consumer products and services businesses. Her diverse experience spans various industries, showcasing her expertise in operations, consulting, leadership, and strategic planning. 

Ian Rentsch

Ian is a globally experienced industry leader with over 25 years of experience in the pharmaceutical and life sciences sector. He has worked with leading organizations across the globe holding various senior and executive leadership positions including Global CROs, Health Technology, RWD & RWE companies as well as Genomic LABS developing a comprehensive understanding of clinical development and real-world evidence generation.  His career has been largely focused on driving innovation and growth in the life sciences and biotechnology sectors, most recently in the area of genetic diagnostics and evidence generation in rare diseases.